Updated Program

Wednesday September 25th

 Arrival in the afternoon. 

 Registration opened at 17:30

18:30 Opening of the workshop
  Organizing committee
18:35 - 18:45

 

Presentation of the "Tumour targeting, Imaging, Radiotherapies network" of the Cancéropôle Grand Ouest

  Michel Chérel, CRCINA, UMR 1232 INSERM ERL CNRS 6001, University of Nantes, France.

 

18:45 - 19:05

 

 

 

 

 

Sponsor communications

 

“How to measure ligand interactions on living cells in real-time”

Hadis Honarvar, Ridgeview Instruments, Sweden

 

 

“MOLECUBES, presenting the CUBES: high-end preclinical imaging PET, SPET and CT systems and selected applications” –  MOLECUBES - Belgium

 

19:05 - 20:00

“PET and SPECT in cancer imaging”

 

 

 

 

Invited speaker: Bart Cornelissen, Radiopharmaceuticals and Molecular Imaging Group, Department of Oncology, University of Oxford, United-Kingdom

 

20:15 Dinner

Thursday September 26th

Session 1: Contribution of imaging in diagnosis

9:00 - 9:30

 

“The role of chelators in developing receptor-targeted radiopharmaceuticals: historical importance and future challenges”

  Invited speaker: Michelle Ma, Imaging Chemistry & Biology Department, Kings College London, United-Kingdom.
   

9:30 - 10:30

3 selected talks of young researchers
   
  “Copper-64 PET Imaging Radiopharmaceuticals based on 1,4,7-Triazacyclononane Bifunctional Chelators for the Diagnostic of Prostate Cancer “
Axia Marlin, Equipe COSM Chimie Organique Santé et Matériaux, UBO, UMR CNRS 6521 CEMCA, Brest, France.
   
  “AlF-18-Labeling and in vivo study of new AMP-based chelators for applications in Positron Emission Tomography Imaging“
Lisa Russelli, Nuclear Medicine Department, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
   
  “A universal method for the radioiodination and astatination of antibodies: easy access to I/At based theranostic tools”
Marion Berdal, CRCINA, Inserm, CNRS, Université de Nantes, Nantes, France.
   
10:30 - 11:00 Poster session & Coffee break
   

11:00 - 12:00

3 selected talks of young researchers

   
 

“Towards the development of novel Zr89 chelators for use in PET imaging “
Joseph Cowell, Chimie ParisTech, CNRS, 75014, Paris, France.

   
  “Radiomics for Disease Free Survival prediction using pre-treatment FDG PET images”
Marta Ferreira, GIGA-CRC in vivo Imaging, University of Liège, Liège, Belgium.
   
  “Automated cervical primary tumor functional volume segmentation in PET images“
Andrei Iantsen, LaTIM, INSERM, UMR 1101, University Brest, Brest, France.
   

12:00 - 12:10

 

“EuroBioimaging: Open access to imaging facilities for the biomedical community”
  Giuseppe Digilio, Department of Science and Technological Innovation, University of Eastern Piedmont “A. Avogadro”, Italy.
   
12:10 - 12:15 Sponsor communication
  “French networks for Cancerology and Nuclear Medecine: ILIAD SIRIC and IRON Labex”, Michel Chérel, CRCINA, Nantes, France.
   
12:20 Lunch
   

14:00 - 14:30

“Diagnostic applications of vibrational imaging in oncology”

 

Invited speaker: Olivier Piot, BioSpecT (Translational BioSpectroscopy) EA 7506, Université de Reims Champagne-Ardenne, Reims, France.

 

14:30 - 14:50

Sponsor communications

 

“High performance integrated PET, SPECT, Optical & X-ray Tomography”, Tom van Rooij, MILabs, Utrecht, The Netherlands.

   
 

Presentation of « Société Française du Cancer » and « Bulletin du Cancer ». Stéphane Supiot, ICO & CRCINA, Saint-Herblain, France.

   

14:50 - 15:50

3 selected talks of young researchers

   
 

"Concept, synthesis and radiolabelling of MCT1 and MCT4 iodinated inhibitors“
Leslie Bitard, Université Clermont Auvergne, INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, France.

   
  “On-demand self-assembling peptide amphiphiles for cancer“
Valentina Del Genio, Department of Pharmacy, University of Naples Federico II, Naples, Italy.
   
  “In the Search of Aza-Macrocycles based PDT-Theranostic Probes”
Laura Abad Galán, Laboratoire de Chimie ENS de Lyon, France.
   
15:50 - 16:10 Coffee break
   
16:10 - 17:10 3 selected talks of young researchers
   
   “A New Biocompatible Diphosphine-peptide Chelator: Attaching Peptides to Radioactive 99mTc(V) for Targeted SPECT Imaging of Disease“
Ingebjørg N. Hungnes, King’s College London, London, United-Kingdom.
   
  “Self-assemblies: in vivo activities on lung cancer”
Abdallah Ladaycia,
Micro et Nanomedecines Translationnelles, MINT, UNIV Angers, UMR INSERM 1066, UMR CNRS 6021, Angers, France.
   
  “GATG Dendrimer and Dendrimer based Polyion Complex (PIC) micelle for SPECT/MRI diagnostic”
Ulung Khoe, GLIAD team, CRCINA, INSERM 1232 and Plateforme de Radiobiologie et d’IMagerie EXpérimentale, PRIMEX, SFR ICAT 4208, Université Angers, UMR-S1066, Angers, France.

Focus on Ultrasound Imaging

17:10 - 17:35 “Photoacoustics imaging: Principle and applications in oncology”.
  Jean-Michel Escoffre, Imaging and Brain, UMR INSERM 1253, Tours, France.
   

17:35 - 18:00

 

 

“Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases”
  Paul-Armand Dujardin, Clinical Investigation Center - Technological Innovation, CHRU, Tours, France.
   
20:00 Dinner
   

Friday September 27th

Session 2: Contribution of imaging in therapeutic follow-up and evaluation

9:00 - 9:30

"Metal Complexes as Diagnostics and Therapeutics"

 

Invited speaker: Gilles Gasser, Laboratory for Inorganic Chemical Biology, Chimie ParisTech , PSL University, Paris, France.

 

9:30 - 10:30

3 selected talks of young researchers

   
 

“New channels for mass cytometry by improving metal chelate inertness”
Laura Grenier, UBO, UFR Sciences, IBSAM, UMR CNRS 6521 « Chimie Electrochimie Moléculaires et Chimie Analytique », Brest, France.

   
 

“Influence of trastuzumab co-treatment on GRPR-targeted therapy of prostate cancer“
Bogdan Mitran, Department of Medicinal Chemistry, Uppsala University, Sweden.

   
 

“Development and Evaluation of Nanosystems for Photodynamic Therapy Triggered by Bioluminescence”
Marcelina Abal-Sanisidro, Nano-oncology Unit. Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

   
10:30 - 11:00 Poster session & Coffee break
   

11:00 - 12:00

3 selected talks of young researchers

   
 

“Therapeutic use of siRNA complexed with dendrimers“
Kamila Białkowska, Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz & Molecular and Nanostructural Biophysics Laboratory, Poland.

   
 

“Radioluminiscent BODIPY-conjugated nanomaterials: towards the activation of PDT in deep tissue and during radiation therapy“
Carlotta Figliola, Laboratoire de Chimie, Ecole Normale Supérieure in Lyon, UMR 5182, Lyon, France.

   
 

“Elaboration of nanocarriers based on poly (β-malic acid) derivatives to encapsulate radionuclides for diagnostic or/and treatment of hepatocellular carcinoma“
Clarisse Brossard, Univ Rennes, Ecole Nationale Supérieure de Chimie de Rennes, CNRS, ISCR – UMR 6226 & Univ Rennes, Inserm, INRA, Institut NUMECAN (Nutrition Metabolisms and Cancer), UMR_A 1341, UMR_S 1241, Rennes, France.

   
12:15 Lunch
   

14:00 - 14:30

“Focus on therapeutic monitoring by FDG PET for solid tumours”

 

Invited speaker: Caroline Rousseau, Nuclear Medicine Department, ICO, integrated Center for Oncology, Nantes, France.

 

14:30 - 15:30 3 selected talks of young researchers
   
  “A receptor amenable to a theranostic approach in ovarian cancer”
Tashbib Khan, Mater Research Institute – The University of Queensland, Translational Research Institute, & Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, Queensland, Australia.
   
  “Novel morphological imaging biomarkers and prognostic mathematical models in glioblastoma”
Julián Pérez-Beteta, Mathematical Oncology Laboratory (Môlab), University of Castilla-La Mancha, Spain.
   
  “A microstructural dosimetry model for the investigation of SIRT treatment “
Federico Budelli, Veronica Carcereri,
Université de Rennes 1, LTSI, INSERM, U1099, Rennes, France &  Laboratory of Biological Structure Mechanics (LaBS), Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Milan, Italy.
   
15:30 - 16:00 Coffee break
   

16:00 - 17:00

3 selected talks of young researchers

   
 

“Development of a CT based radiomic model predictive of non-response to induction chemotherapy for laryngeal cancers”
Ingrid Masson, LaTIM, INSERM, UMR 1101, Univ Brest, IBSAM, Brest, France.

   
  “Identification of protein targets for the development of cancer theranostic agents“
Thomas Kryza, Mater Research Institute, The University of Queensland, Translational Research Institute, Brisbane, Australia.
   
  “Improving the Stability of a Sialidase-Activated Fluorescence Probe for the Visualisation of Lung Cancer”
Charlotte Rivas, Department of Imaging Chemistry and Biology, King’s College London, United-Kingdom.
   
17:00
Social event

Saturday September 28th

Session 3: Emerging imaging technologies 

8:30 - 9:00

"Recent technological developments in PET imaging"

  Invited speaker: Dimitris Visvikis, LaTIM, National Institute of Health & Clinical Sciences, Brest, France.
   

9:00 - 9:30

 

"Targeting changes in the glycocalyx in the circulatory system using lanthanide complexes"
  Invited speaker: Thomas Just Sorensen, Nano-Science Center & Department of Chemistry, University of Copenhagen, Denmark.
   
9:30 - 10:30 3 selected talks of young researchers
   
  “Standardization of MTV computation: acquisition time and segmentation algorithm matter”
Anna Borra, Nuclear Medicine Department, University of Genoa, Italy.
   
  “Prognostic models based on imaging findings in glioblastoma: Human versus Machine”
David Molina-García, Mathematical Oncology Laboratory (Môlab), University of Castilla-La Mancha, Spain.
   
  “CT lung segmentation using adaptive thresholding“
Fadila Zerka, The-D Lab, Precision Medicine, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands & Oncoradiomics SA, Liège, Belgium.
   
10:30 - 10:45 Coffee break
   
10:45 - 11:45 3 selected talks of young researchers
   
  “Prognostic value of stable CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer patients”
Concetta Piazzese, School of Engineering, Cardiff University & Velindre Cancer Centre Cardiff, United Kingdom.
   
  “Radiomic feature preselection to improve survival prediction after radiotherapy for hepatocellular carcinoma”
Pierre Fontaine, Rennes, CLCC Eugene Marquis, INSERM, LTSI - UMR 1099, Rennes, France & University of Applied Sciences Western Switzerland (HES-SO), Sierre, Switzerland.
   
  “Deep Convolutional Neural Network to predict 1p19q co-deletion and IDH1 mutation status from MRI in Low Grade Gliomas“
Sarah Rosas González,
UMR U1253 iBrain, Université de Tours, Inserm, Tours, France.
   
12:00 Lunch
   
13:10 End of the workshop - Departure

Other informations

Scientific sessions:

- Duration of selected talks is 20 minutes incl. questions.

 

Poster session:

- The format of poster is A0.

- Discussion around the posters will be possible during all coffee breaks. Posters should therefore be hanged for the entire duration of the workshop.